Synthesis and Properties of a Mitochondrial Peripheral Benzodiazepine Receptor Conjugate

被引:18
作者
El Alaoui, Abdessamad [1 ,2 ]
Schmidt, Frederic [1 ,2 ]
Sarr, Marianne [3 ,4 ]
Decaudin, Didier [3 ,5 ,6 ]
Florent, Jean-Claude [1 ,2 ]
Johannes, Ludger [3 ,4 ]
机构
[1] Ctr Rech Concept, Inst Curie, F-75248 Paris 05, France
[2] CNRS, UMR 176, F-75700 Paris, France
[3] Ctr Rech, Inst Curie, Lab Traf, F-75248 Paris 05, France
[4] CNRS, UMR 144, F-75700 Paris, France
[5] Inst Curie, Hop Dept Clin Haematol, Lab Preclin Invest, F-75248 Paris, France
[6] Inst Curie, Lab Preclin Invest, Translat Res Dept, F-75248 Paris, France
关键词
antitumor agents; drug delivery; prodrugs; benzodiazepine; shiga toxin;
D O I
10.1002/cmdc.200800249
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Peripheral benzodiazepine receptors are potential targets for cancer therapeutics through the use of specific ligands such as the pro-apoptotic benzodiazepine RO5-4864, However, the poor water solubility of this compound has been a limitation to its application in vivo. Herein we describe an efficient synthesis for the conjugation, via a cleavable linker arm, of RO5-4864 to a novel tumour-delivery tool, the B-subunit of Shiga toxin (STxB). The conjugate is water soluble and specifically targets cancer cells that overexpress the glycolipid Gb3, the cellular Shiga toxin receptor that is found on several human tumours. After internalisation via retrograde transport, the prodrug is cleaved inside cells to release the active principle. Delivery by STxB therefore increases the cytotoxic activity of RO5-4864 and its tumour specificity.
引用
收藏
页码:1687 / 1695
页数:9
相关论文
共 40 条
[1]   IMPROVED INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE [J].
ABE, A ;
INOKUCHI, J ;
JIMBO, M ;
SHIMENO, H ;
NAGAMATSU, A ;
SHAYMAN, JA ;
SHUKLA, GS ;
RADIN, NS .
JOURNAL OF BIOCHEMISTRY, 1992, 111 (02) :191-196
[2]  
ANHOLT RRH, 1986, J BIOL CHEM, V261, P576
[3]   Relation of cell proliferation to expression of peripheral benzodiazepine receptors in human breast cancer cell lines [J].
Beinlich, A ;
Strohmeier, R ;
Kaufmann, M ;
Kuhl, H .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (03) :397-402
[4]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[5]   Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities [J].
Bono, F ;
Lamarche, I ;
Prabonnaud, V ;
Le Fur, G ;
Herbert, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (02) :457-461
[6]  
BUNDGAARD H, 1989, Advanced Drug Delivery Reviews, V3, P39, DOI 10.1016/0169-409X(89)90004-5
[7]   ISOLATION, PURIFICATION AND PARTIAL SEQUENCE OF A NEUROPEPTIDE (DIAZEPAM-BINDING INHIBITOR) PRECURSOR OF AN ANXIOGENIC PUTATIVE LIGAND FOR BENZODIAZEPINE RECOGNITION SITE [J].
CORDA, MG ;
FERRARI, M ;
GUIDOTTI, A ;
KONKEL, D ;
COSTA, E .
NEUROSCIENCE LETTERS, 1984, 47 (03) :319-324
[8]   Peripheral benzodiazepine receptor and its clinical targeting [J].
Decaudin, D .
ANTI-CANCER DRUGS, 2004, 15 (08) :737-745
[9]  
Decaudin D, 2002, CANCER RES, V62, P1388
[10]   Shiga toxin-mediated retrograde delivery of a topoisomerase I inhibitor prodrug [J].
El Alaoui, Abdessamad ;
Schmidt, Frederic ;
Amessou, Mohamed ;
Sarr, Marianne ;
Decaudin, Didier ;
Florent, Jean-Claude ;
Johannes, Ludger .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (34) :6469-6472